Experts Put South Korea’s Annual Obesity Cost Above KRW 23T
Obesity experts estimated that adult obesity costs South Korea more than KRW 23 trillion annually and called for integrated national management of the chronic disease.
This article was automatically drafted and passed editorial compliance checks. It synthesizes public source metadata and is not a substitute for individual care or clinical review.
At a policy forum held by the Korean Society for the Study of Obesity on September 3, experts framed adult obesity as a chronic disease requiring coordinated national management rather than solely a matter of personal weight control.
The experts estimated the annual socioeconomic burden at more than KRW 23 trillion. The calculation encompassed medical spending as well as losses associated with absence from work, reduced productivity while working, and premature death.
What the policy discussion proposed
Experts called for obesity policy to move beyond prevention alone and give greater weight to treatment and continuing management. They also proposed standardizing diagnosis by assessing excess body fat together with clinical signs instead of relying only on body mass index.
The policy proposals included gradually widening insurance support for medication, surgery, and nutrition counseling, with priority for higher-risk and vulnerable groups. Experts connected better access to treatment with the goal of reducing obesity-related disease risk and socioeconomic losses.
Context and reporting limits
Experts highlighted rapidly rising obesity among adults in their 20s through 40s because these age groups are economically active. Their analysis therefore treated obesity as both a health issue and a factor affecting labor productivity.
The reports describe a national cost estimate and policy proposals, not the expected result of a particular treatment for an individual. They do not establish exact effectiveness, side effects, recovery, or personal cost, and individual variation requires a qualified clinician to assess treatment choices.
Questions for a clinical consultation
A patient can consult a qualified physician about whether an assessment should consider body mass index, excess body fat, and clinical signs together. The discussion can also cover whether medication, surgery, nutrition counseling, or another management approach fits the patient’s health status.
Before choosing treatment, ask how personal risk factors could affect side effects and recovery, what follow-up may be appropriate, and which costs or insurance terms apply. A clinician should tailor those answers to individual variation rather than to the national estimate.
Frequently asked questions
How much does adult obesity cost South Korea each year?
Experts estimated the annual burden at more than KRW 23 trillion. Their calculation included medical spending and losses linked to work absence, reduced on-the-job productivity, and premature death.
Why do experts want obesity managed as a chronic disease?
Experts linked obesity to disease risk, medical expenditure, and productivity losses, and argued that personal weight control alone is insufficient. They proposed integrated national policies spanning prevention, treatment, and continuing management.
Is body mass index alone enough for an obesity assessment?
Experts proposed moving beyond body mass index alone by considering excess body fat and clinical signs together. A qualified physician should determine how that broader assessment applies to an individual patient.
Questions to take to your clinician
- Should my assessment consider body fat and clinical signs as well as body mass index?
- Which treatment or management options fit my health status and risk factors?
- What side effects and recovery considerations apply to each option?
- What follow-up, personal costs, and insurance terms should I expect?
MediIndex articles are for general information only and are not medical advice, diagnosis, or advertising. Outcomes vary by individual — consult a board-certified specialist for personal decisions.
